Its sleep benefit comes from restoring the pineal glands melatonin output capacity, which declines significantly with age
Human clinical-trial data (Phase 1/2 studies in wound healing, cardiac injury, and dry eye) exist only for a different, full-length recombinant thymosin beta-4 product, not for the short synthetic fragment marketed as TB-500, so no completed published human trial has evaluated TB-500 specifically for muscle, tendon, or joint recovery
It operates on a circadian rhythm
This comparison is for general orientation only
When the FDA is actively removing bad actors but not providing a clean alternative pathway for many of these compounds, consumers need transparent, unbiased sources of verification more than ever